15 results on '"Chedik L"'
Search Results
2. Reflections on the OECD guidelines for in vitro skin absorption studies
- Author
-
10101268 - Du Plessis, Johannes Lodewykus, 12776998 - Franken, Anja, Hopf, N.B., Du Plessis, J.L., Franken, A., Frasch, F., Champmartin, C., Schenk, L., Berthet, A., Chedik, L., Gaskin, S., 10101268 - Du Plessis, Johannes Lodewykus, 12776998 - Franken, Anja, Hopf, N.B., Du Plessis, J.L., Franken, A., Frasch, F., Champmartin, C., Schenk, L., Berthet, A., Chedik, L., and Gaskin, S.
- Abstract
At the 8th conference of Occupational and Environmental Exposure of the Skin to Chemicals (OEESC) (16–18 September 2019) in Dublin, Ireland, several researchers performing skin permeation assays convened to discuss in vitro skin permeability experiments. We, along with other colleagues, all of us hands-on skin permeation researchers, present here the results from our discussions on the available OECD guidelines. The discussions were especially focused on three OECD skin absorption documents, including a recent revision of one: i) OECD Guidance Document 28 (GD28) for the conduct of skin absorption studies (OECD, 2004), ii) Test Guideline 428 (TGD428) for measuring skin absorption of chemical in vitro (OECD, 2004), and iii) OECD Guidance Notes 156 (GN156) on dermal absorption issued in 2011 (OECD, 2011). GN156 (OECD, 2019) is currently under review but not finalized. A mutual concern was that these guidance documents do not comprehensively address methodological issues or the performance of the test, which might be partially due to the years needed to finalize and update OECD documents with new skin research evidence. Here, we summarize the numerous factors that can influence skin permeation and its measurement, and where guidance on several of these are omitted and often not discussed in published articles. We propose several improvements of these guidelines, which would contribute in harmonizing future in vitro skin permeation experiments.
- Published
- 2020
3. Reflections on the OECD guidelines for in vitro skin absorption studies
- Author
-
F. Marquet, F. Larese Filon, Gunnar Johanson, Nancy B. Hopf, L. Chedik, J.L. Du Plessis, Sharyn Gaskin, Annette L. Bunge, Gerald B. Kasting, Anja Franken, Aurélie Berthet, F. Frasch, S. Kilo, Linda Schenk, C. Champmartin, Elena Reale, Klara Midander, Anneli Julander, Hopf, N. B., Champmartin, C., Schenk, L., Berthet, A., Chedik, L., Du Plessis, J. L., Franken, A., Frasch, F., Gaskin, S., Johanson, G., Julander, A., Kasting, G., Kilo, S., Larese Filon, F., Marquet, F., Midander, K., Reale, E., Bunge, A. L., 10101268 - Du Plessis, Johannes Lodewykus, and 12776998 - Franken, Anja
- Subjects
medicine.medical_specialty ,Diffusion cell ,Skin Absorption ,Time lag ,Percutaneous permeation ,Skin permeability ,010501 environmental sciences ,Toxicology ,030226 pharmacology & pharmacy ,01 natural sciences ,Hazardous Substances ,Chemical skin absorption ,In vitro skin permeation tests ,OECD guideline 428 ,Skin absorption ,Skin permeation ,Skin permeation coefficient ,03 medical and health sciences ,0302 clinical medicine ,Occupational Exposure ,Humans ,Medicine ,Medical physics ,Organisation for Economic Co-Operation and Development ,0105 earth and related environmental sciences ,Research evidence ,In vitro skin permeation test ,integumentary system ,business.industry ,Guidance documents ,Environmental Exposure ,General Medicine ,Environmental exposure ,Congresses as Topic ,Guideline Adherence ,business ,Ireland - Abstract
At the 8th conference of Occupational and Environmental Exposure of the Skin to Chemicals (OEESC) (16–18 September 2019) in Dublin, Ireland, several researchers performing skin permeation assays convened to discuss in vitro skin permeability experiments. We, along with other colleagues, all of us hands-on skin permeation researchers, present here the results from our discussions on the available OECD guidelines. The discussions were especially focused on three OECD skin absorption documents, including a recent revision of one: i) OECD Guidance Document 28 (GD28) for the conduct of skin absorption studies (OECD, 2004), ii) Test Guideline 428 (TGD428) for measuring skin absorption of chemical in vitro (OECD, 2004), and iii) OECD Guidance Notes 156 (GN156) on dermal absorption issued in 2011 (OECD, 2011). GN156 (OECD, 2019) is currently under review but not finalized. A mutual concern was that these guidance documents do not comprehensively address methodological issues or the performance of the test, which might be partially due to the years needed to finalize and update OECD documents with new skin research evidence. Here, we summarize the numerous factors that can influence skin permeation and its measurement, and where guidance on several of these are omitted and often not discussed in published articles. We propose several improvements of these guidelines, which would contribute in harmonizing future in vitro skin permeation experiments.
- Published
- 2020
- Full Text
- View/download PDF
4. Percutaneous absorption of two bisphenol a analogues, BPAF and TGSA: Novel In vitro data from human skin.
- Author
-
Champmartin C, Seiwert C, Aubertin M, Joubert E, Marquet F, Chedik L, and Cosnier F
- Subjects
- Humans, Permeability, Adult, Female, Fluorocarbons, Skin Absorption, Phenols, Benzhydryl Compounds, Skin metabolism
- Abstract
Bisphenol AF (BPAF) and TGSA are analogues of Bisphenol A (BPA). BPAF is used in polymer synthesis, while TGSA is applied in thermal papers. The EU classifies BPAF as toxic to reproduction and TGSA as a skin sensitizer. However, TGSA's other health effects remain unclear. BPAF contamination has been noted among electronic waste workers, and TGSA exposure is documented in various professions. Despite the significance of skin contact, data on skin permeation rates for BPAF and TGSA are limited. This study aimed to generate percutaneous absorption data for BPAF and TGSA following OECD guidelines. [14C]-labeled BPAF or TGSA was applied to human skin samples in vitro using Franz diffusion cells for 20 and 40 h, respectively. Key parameters such as steady-state flux, lag time, and skin permeability coefficient (K
p ) were calculated. Furthermore, the distribution of the dose across different compartments, particularly within the skin, was evaluated at the conclusion of the experiment. Sequential strippings and epidermis-dermis separation were conducted for BPAF to predict the potential absorption of the remaining dose present within the skin. The permeability coefficients for BPAF and TGSA were found to be 1.9 E-03 and 1.6 E-03 cm/h, with 22% and 23% of the applied doses absorbed, respectively. Both chemicals are classified as "fast" penetrants based on their Kp values. These findings suggest that BPAF and TGSA are absorbed through the skin, highlighting potential occupational risks through dermal exposure. The new percutaneous absorption data will enhance the assessment of the occupational risks., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
5. Human in vitro percutaneous absorption of bisphenol S: Assessment of the skin reservoir and occlusion effects.
- Author
-
Marquet F, Champmartin C, Seiwert C, Aubertin M, Viton S, Chedik L, and Cosnier F
- Subjects
- Humans, In Vitro Techniques, Female, Male, Adult, Middle Aged, Skin Absorption, Phenols pharmacokinetics, Phenols toxicity, Skin metabolism, Sulfones pharmacokinetics
- Abstract
Bisphenol S (BPS) was introduced in many industrial and commercial applications as a presumed safer alternative to bisphenol A. However, concerns have been raised surrounding skin absorption and potential persistence of BPS and its related toxic effects in humans. A previous study revealed the likelihood of a reservoir building up in exposed skin. Here, we studied the interactions of BPS solubilized in acetone, ultrapure water, or artificial sebum with freshly excised human skin samples. In vitro tests were performed in static Franz diffusion cells, to explore reservoir and occlusion effects, absorption and metabolism. Most BPS passed through the skin without metabolization - <10% was recovered as glucuronide or sulfate conjugates. Importantly, a substantial amount of BPS persisted in the skin, especially in the stratum corneum. This reservoir could lead to prolonged diffusion into the body after surface cleaning. Occlusion, that may occur with protective clothing, amplified BPS absorption up to six-fold. These findings have implications for occupational settings, highlighting the persistence of BPS contamination even after washing the skin's surface and the need to ensure protective equipment is correctly maintained and used., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023. Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
6. Benchmarking of BMDC assay and related QSAR study for identifying sensitizing chemicals.
- Author
-
Chedik L, Baybekov S, Marcou G, Cosnier F, Mourot-Bousquenaud M, Jacquenet S, Varnek A, and Battais F
- Subjects
- Humans, Animals, Support Vector Machine, Computer Simulation, Dermatitis, Allergic Contact, Allergens toxicity, Animal Testing Alternatives methods, Bone Marrow Cells drug effects, Local Lymph Node Assay, Mice, Quantitative Structure-Activity Relationship, Benchmarking, Dendritic Cells drug effects
- Abstract
The Bone-Marrow derived Dendritic Cell (BMDC) test is a promising assay for identifying sensitizing chemicals based on the 3Rs (Replace, Reduce, Refine) principle. This study expanded the BMDC benchmarking to various in vitro, in chemico, and in silico assays targeting different key events (KE) in the skin sensitization pathway, using common substances datasets. Additionally, a Quantitative Structure-Activity Relationship (QSAR) model was developed to predict the BMDC test outcomes for sensitizing or non-sensitizing chemicals. The modeling workflow involved ISIDA (In Silico Design and Data Analysis) molecular fragment descriptors and the SVM (Support Vector Machine) machine-learning method. The BMDC model's performance was at least comparable to that of all ECVAM-validated models regardless of the KE considered. Compared with other tests targeting KE3, related to dendritic cell activation, BMDC assay was shown to have higher balanced accuracy and sensitivity concerning both the Local Lymph Node Assay (LLNA) and human labels, providing additional evidence for its reliability. The consensus QSAR model exhibits promising results, correlating well with observed sensitization potential. Integrated into a publicly available web service, the BMDC-based QSAR model may serve as a cost-effective and rapid alternative to lab experiments, providing preliminary screening for sensitization potential, compound prioritization, optimization and risk assessment., Competing Interests: Declaration of competing interest The authors declare no conflicts of interest., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. An update of skin permeability data based on a systematic review of recent research.
- Author
-
Chedik L, Baybekov S, Cosnier F, Marcou G, Varnek A, and Champmartin C
- Subjects
- Permeability, Datasets as Topic, Humans, Skin metabolism, Skin Absorption, Xenobiotics metabolism
- Abstract
The cutaneous absorption parameters of xenobiotics are crucial for the development of drugs and cosmetics, as well as for assessing environmental and occupational chemical risks. Despite the great variability in the design of experimental conditions due to uncertain international guidelines, datasets like HuskinDB have been created to report skin absorption endpoints. This review updates available skin permeability data by rigorously compiling research published between 2012 and 2021. Inclusion and exclusion criteria have been selected to build the most harmonized and reusable dataset possible. The Generative Topographic Mapping method was applied to the present dataset and compared to HuskinDB to monitor the progress in skin permeability research and locate chemotypes of particular concern. The open-source dataset (SkinPiX) includes steady-state flux, maximum flux, lag time and permeability coefficient results for the substances tested, as well as relevant information on experimental parameters that can impact the data. It can be used to extract subsets of data for comparisons and to build predictive models., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
8. Interactions of organophosphorus pesticides with ATP-binding cassette (ABC) drug transporters.
- Author
-
Chedik L, Mias-Lucquin D, Fardel O, Delalande O, and Bruyere A
- Subjects
- ATP Binding Cassette Transporter, Subfamily B metabolism, ATP Binding Cassette Transporter, Subfamily G, Member 2 metabolism, ATP-Binding Cassette Transporters metabolism, Adenosine Triphosphate, Drug Interactions, Membrane Transport Proteins, Neoplasm Proteins metabolism, Organophosphorus Compounds, Pharmaceutical Preparations, Naled, Pesticides pharmacology, Phosmet
- Abstract
Although pharmaceutical companies have to study drug-transporter interaction, environmental contaminant interactions with these transporters are not well characterised. In this study, we demonstrated using in vitro transfected cell line that some organophosphorus pesticides are able to interact with drug efflux transporters like P-glycoprotein, BCRP and MRPs.According to our results, dibrom was found to inhibit only Hoechst binding site of P-gp with an IC
50 closed to 77 µM, phosmet inhibited BCRP efflux with an IC50 of 42 µM and only profenofos was able to inhibit BCRP, MRPs and P-gp at two binding sites. As profenofos appeared to be a potent ABC transporter inhibitor, we studied its potential substrate property towards P-gp.Using a docking approach, we developed an in silico tool to study pesticide properties to be a probe or inhibitor of P-gp transporter. From both in silico and in vitro results, profenofos was not considered as a P-gp substrate.Combining both in vitro and docking methods appears to be an attractive approach to select pesticides that would not pass into the blood systemic circulation.- Published
- 2022
- Full Text
- View/download PDF
9. Occupational exposure assessment with solid substances: choosing a vehicle for in vitro percutaneous absorption experiments.
- Author
-
Champmartin C, Chedik L, Marquet F, and Cosnier F
- Subjects
- Acetone metabolism, Animals, Ethanol, Humans, Skin, Water metabolism, Occupational Exposure, Skin Absorption
- Abstract
Percutaneous occupational exposure to industrial toxicants can be assessed in vitro on excised human or animal skins. Numerous factors can significantly influence skin permeation of chemicals and the flux determination. Among them, the vehicle used to solubilize the solid substances is a tricky key step. A "realistic surrogate" that closely matches the exposure scenario is recommended in first intention. When direct transposition of occupational exposure conditions to in vitro experiments is impossible, it is recommended that the vehicle used does not affect the skin barrier (in particular in terms of structural integrity, composition, or enzymatic activity). Indeed, any such effect could alter the percutaneous absorption of substances in a number of ways, as we will see. Potential effects are described for five monophasic vehicles, including the three most frequently used: water, ethanol, acetone; and two that are more rarely used, but are realistic: artificial sebum and artificial sweat. Finally, we discuss a number of criteria to be verified and the associated tests that should be performed when choosing the most appropriate vehicle, keeping in mind that, in the context of occupational exposure, the scientific quality of the percutaneous absorption data provided, and how they are interpreted, may have long-range consequences. From the narrative review presented, we also identify and discuss important factors to consider in future updates of the OECD guidelines for in vitro skin absorption experiments.
- Published
- 2022
- Full Text
- View/download PDF
10. Human in vitro percutaneous absorption of bisphenol S and bisphenol A: A comparative study.
- Author
-
Champmartin C, Marquet F, Chedik L, Décret MJ, Aubertin M, Ferrari E, Grandclaude MC, and Cosnier F
- Subjects
- Administration, Cutaneous, Biotransformation, Humans, Occupational Exposure analysis, Paper, Benzhydryl Compounds metabolism, Phenols metabolism, Skin metabolism, Skin Absorption physiology, Sulfones metabolism
- Abstract
Bisphenol A (BPA) is widely used in industrial products. Due to the toxicity of this compound, and to comply with restrictions and regulations, manufacturers have progressively replaced it by substitutes. One of the main substitutes used is bisphenol S (BPS). Despite increasing use in many products, the effects of BPS on human health have been little investigated, and studies on percutaneous BPS absorption and particularly toxicokinetic data are lacking. However, the endocrine-disrupting activity of BPA and BPS appears comparable. Dermal contact is a significant source of occupational exposure and is the main route during handling of bisphenol-containing receipts by cashiers. Here, percutaneous BPS absorption was investigated and compared to that of BPA. Experiments were performed according to OECD guidelines. Test compounds dissolved in a vehicle - acetone, artificial sebum or water - were applied in vitro to fresh human skin samples in static Franz diffusion cells. Flux, cumulative absorbed dose and distribution of dose recovered were measured. BPA absorption was vehicle-dependent ranging from 3% with sebum to 41% with water. BPS absorption was much lower than BPA absorption whatever the vehicle tested (less than 1% of applied dose). However, depending on the vehicle 20% to 47% of the applied BPS dose remained in the skin, and was consequently potentially absorbable. Both BPA and BPS were mainly absorbed without biotransformation. Taken together, these results indicate that workers may be exposed to BPS through skin when handling products containing it. This exposure is of concern as its toxicity is currently incompletely understood., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
11. Interactions of organophosphorus pesticides with solute carrier (SLC) drug transporters.
- Author
-
Chedik L, Bruyere A, and Fardel O
- Subjects
- Drug-Related Side Effects and Adverse Reactions, Environmental Exposure, HEK293 Cells, Humans, Organophosphorus Compounds chemistry, Pesticides chemistry, Solute Carrier Proteins chemistry
- Abstract
1. Organophosphorus pesticides (OPs) are known to interact with human ATP-binding cassette drug efflux pumps. The present study was designed to determine whether they can also target activities of human solute carrier (SLC) drug transporters. 2. The interactions of 13 OPs with SLC transporters involved in drug disposition, such as organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), organic anion transporters (OATs) and organic anion transporting polypeptides (OATPs), were mainly investigated using transporter-overexpressing cell clones and fluorescent or radiolabeled reference substrates. 3. With a cut-off value of at least 50% modulation of transporter activity by 100 µM OPs, OAT1 and MATE2-K were not impacted, whereas OATP1B1 and MATE1 were inhibited by two and three OPs, respectively. OAT3 activity was similarly blocked by three OPs, and was additionally stimulated by one OP. Five OPs cis-stimulated OATP2B1 activity. Both OCT1 and OCT2 were inhibited by the same eight OPs, including fenamiphos and phosmet, with IC
50 values however in the 3-30 µM range, likely not relevant to environmental exposure. 4. These data demonstrated that various OPs inhibit SLC drug transporter activities, especially those of OCT1 and OCT2, but only when used at high concentrations not expected to occur in environmentally-exposed humans.- Published
- 2019
- Full Text
- View/download PDF
12. Interactions of pesticides with membrane drug transporters: implications for toxicokinetics and toxicity.
- Author
-
Chedik L, Bruyere A, Bacle A, Potin S, Le Vée M, and Fardel O
- Subjects
- ATP Binding Cassette Transporter, Subfamily B, Member 1 metabolism, Animals, Biological Transport, Computer Simulation, Environmental Exposure adverse effects, Environmental Pollutants chemistry, Environmental Pollutants pharmacokinetics, Humans, Organic Cation Transport Proteins metabolism, Pesticides chemistry, Pesticides pharmacokinetics, Toxicokinetics, Environmental Pollutants toxicity, Membrane Transport Proteins metabolism, Pesticides toxicity
- Abstract
Introduction: Drug transporters are now recognized as major actors of pharmacokinetics. They are also likely implicated in toxicokinetics and toxicology of environmental pollutants, notably pesticides, to which humans are widely exposed and which are known to exert various deleterious effects toward health. Interactions of pesticides with drug transporters are therefore important to consider. Areas covered: This review provides an overview of the interactions of pesticides with membrane drug transporters, i.e. inhibition of their activity, regulation of their expression, and handling of pesticides. Consequences for toxicokinetics and toxicity of pesticides are additionally summarized and discussed. Expert opinion: Some pesticides belonging to several chemical classes, such as organochlorine, pyrethroid, and organophosphorus pesticides, have been demonstrated to interact with various uptake and efflux drug transporters, including the efflux pump P-glycoprotein (P-gp) and the uptake organic cation transporters (OCTs). This provides proof of the concept that pesticide-transporter relationships merit attention. More extensive and systematic characterization of pesticide-transporter relationships, possibly through the use of in silico methods, is however likely required. In addition, consideration of transporter polymorphisms, pesticide mixture effects, and realistic pesticide concentrations reached in humans may help better define the in vivo relevance of pesticide-transporter interactions in terms of toxicokinetics and toxicity.
- Published
- 2018
- Full Text
- View/download PDF
13. In Silico Prediction for Intestinal Absorption and Brain Penetration of Chemical Pesticides in Humans.
- Author
-
Chedik L, Mias-Lucquin D, Bruyere A, and Fardel O
- Subjects
- Computer Simulation, Humans, Models, Biological, Neurotoxicity Syndromes, Pesticides toxicity, Brain drug effects, Brain metabolism, Intestinal Absorption physiology, Pesticides pharmacokinetics
- Abstract
Intestinal absorption and brain permeation constitute key parameters of toxicokinetics for pesticides, conditioning their toxicity, including neurotoxicity. However, they remain poorly characterized in humans. The present study was therefore designed to evaluate human intestine and brain permeation for a large set of pesticides ( n = 338) belonging to various chemical classes, using an in silico graphical BOILED-Egg/SwissADME online method based on lipophilicity and polarity that was initially developed for drugs. A high percentage of the pesticides (81.4%) was predicted to exhibit high intestinal absorption, with a high accuracy (96%), whereas a lower, but substantial, percentage (38.5%) displayed brain permeation. Among the pesticide classes, organochlorines ( n = 30) constitute the class with the lowest percentage of intestine-permeant members (40%), whereas that of the organophosphorus compounds ( n = 99) has the lowest percentage of brain-permeant chemicals (9%). The predictions of the permeations for the pesticides were additionally shown to be significantly associated with various molecular descriptors well-known to discriminate between permeant and non-permeant drugs. Overall, our in silico data suggest that human exposure to pesticides through the oral way is likely to result in an intake of these dietary contaminants for most of them and brain permeation for some of them, thus supporting the idea that they have toxic effects on human health, including neurotoxic effects., Competing Interests: The authors declare no conflict of interest.
- Published
- 2017
- Full Text
- View/download PDF
14. Inhibition of SLC drug transporter activities by environmental bisphenols.
- Author
-
Bruyere A, Hubert C, Le Vee M, Chedik L, Sayyed K, Stieger B, Denizot C, Parmentier Y, and Fardel O
- Subjects
- Cell Line, Tumor, HEK293 Cells, Humans, Organic Anion Transporters, Sodium-Independent genetics, Organic Anion Transporters, Sodium-Independent metabolism, Organic Cation Transport Proteins genetics, Organic Cation Transport Proteins metabolism, Benzhydryl Compounds pharmacology, Organic Anion Transporters, Sodium-Independent antagonists & inhibitors, Organic Cation Transport Proteins antagonists & inhibitors, Phenols pharmacology, Polybrominated Biphenyls pharmacology, Sulfones pharmacology
- Abstract
The plastic component bisphenol A (BPA) is suspected to exert deleterious effects towards human health and targets various cellular and molecular pathways, including activity of ATP-binding cassette drug transporters. The present study was designed to determine whether BPA and some derivatives, like its substitutes bisphenol F (BPF) and bisphenol S (BPS) and the flame retardant tetrabromobisphenol A (TBBPA), may additionally interact with solute carrier (SLC) drug transporters. Activities of the various following SLC transporters were inhibited in a major way (by >60%) by 100μM bisphenols: OCT1 and MATE1 (by BPA and TBBPA), OATP1B1 (by BPA, BPF and TBBPA), OATP1B3 and NTCP (by TBBPA) and OAT3 (by BPA, BPF, BPS and TBBPA); by contrast, activities of other transporters were not impacted (MATE2-K) or were stimulated (notably OCT1 by BPS and OCT2 by BPF). Transporter inhibitions due to bisphenols were concentrations-dependent, with half maximal inhibitory concentrations (IC
50 ) ranging from 0.5μM to 73.5μM. BPA was finally shown to be not transported by OAT3, although inhibiting this transporter in a competitive manner. Taken together, these data indicate that bisphenols interact with SLC transporters, at concentration levels however rather higher than those occurring in humans in response to environmental exposure., (Copyright © 2016 Elsevier Ltd. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
15. Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin.
- Author
-
Chedik L, Bruyere A, Le Vee M, Stieger B, Denizot C, Parmentier Y, Potin S, and Fardel O
- Subjects
- ATP-Binding Cassette Transporters metabolism, Allethrins chemistry, Cell Line, Dopamine metabolism, HEK293 Cells drug effects, Humans, Multidrug Resistance-Associated Protein 2, Organic Cation Transporter 1 antagonists & inhibitors, Organic Cation Transporter 1 genetics, Organic Cation Transporter 1 metabolism, Pesticides chemistry, Pyrethrins chemistry, Solute Carrier Proteins metabolism, Structure-Activity Relationship, Toxicity Tests, ATP-Binding Cassette Transporters antagonists & inhibitors, Allethrins toxicity, Pesticides toxicity, Pyrethrins toxicity, Solute Carrier Proteins antagonists & inhibitors
- Abstract
Pyrethroids are widely-used chemical insecticides, to which humans are commonly exposed, and known to alter functional expression of drug metabolizing enzymes. Limited data have additionally suggested that drug transporters, that constitute key-actors of the drug detoxification system, may also be targeted by pyrethroids. The present study was therefore designed to analyze the potential regulatory effects of these pesticides towards activities of main ATP-binding cassette (ABC) and solute carrier (SLC) drug transporters, using transporter-overexpressing cells. The pyrethroids allethrin and tetramethrin were found to inhibit various ABC and SLC drug transporters, including multidrug resistance-associated protein (MRP) 2, breast cancer resistance protein (BCRP), organic anion transporter polypeptide (OATP) 1B1, organic anion transporter (OAT) 3, multidrug and toxin extrusion transporter (MATE) 1, organic cation transporter (OCT) 1 and OCT2, with IC50 values however ranging from 2.6 μM (OCT1 inhibition by allethrin) to 77.6 μM (OAT3 inhibition by tetramethrin) and thus much higher than pyrethroid concentrations (in the nM range) reached in environmentally pyrethroid-exposed humans. By contrast, allethrin and tetramethrin cis-stimulated OATP2B1 activity and failed to alter activities of OATP1B3, OAT1 and MATE2-K, whereas P-glycoprotein activity was additionally moderately inhibited. Twelve other pyrethoids used at 100 μM did not block activities of the various investigated transporters, or only moderately inhibited some of them (inhibition by less than 50%). In silico analysis of structure-activity relationships next revealed that molecular parameters, including molecular weight and lipophilicity, are associated with transporter inhibition by allethrin/tetramethrin and successfully predicted transporter inhibition by the pyrethroids imiprothrin and prallethrin. Taken together, these data fully demonstrated that two pyrethoids, i.e., allethrin and tetramethrin, can act as regulators of the activity of various ABC and SLC drug transporters, but only when used at high and non-relevant concentrations, making unlikely any contribution of these transporter activity alterations to pyrethroid toxicity in environmentally exposed humans., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.